Article
Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion.
Gut - 1 Dec 2003
Lee H C, Suh D J, Ryu S H, Kim H, Shin J W, Lim Y-S, Chung Y-H, Lee Y S
Abstract excerpt
BACKGROUND AND AIMS: Lamivudine induces favourable virological and biochemical responses but post-treatment relapses are frequent, even in patients with hepatitis B e antigen (HBeAg) loss or seroconversion. The aim of this study was to determine whether extended lamivudine therapy for up to 12 mo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.